The adequacy of tissue microarrays in the assessment of inter-and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma ATJ Lee, W Chew, CP Wilding, N Guljar, MJ Smith, DC Strauss, C Fisher, ... Scientific Reports 9 (1), 14602, 2019 | 28 | 2019 |
Extracting DNA from FFPE tissue biospecimens using user-friendly automated technology: is there an impact on yield or quality? W Mathieson, N Guljar, I Sanchez, M Sroya, GA Thomas Biopreservation and biobanking 16 (3), 191-199, 2018 | 18 | 2018 |
Proteomic profiling of soft tissue sarcomas with SWATH mass spectrometry M Milighetti, L Krasny, ATJ Lee, G Morani, C Szecsei, Y Chen, N Guljar, ... Journal of Proteomics 241, 104236, 2021 | 13 | 2021 |
The proteomic landscape of soft tissue sarcomas J Burns, CP Wilding, L Krasny, X Zhu, M Chadha, YB Tam, H Ps, ... Nature Communications 14 (1), 3834, 2023 | 8 | 2023 |
Macrophage-mediated immunoediting drives ductal carcinoma evolution: space is the game changer C Gatenbee, J West, AM Baker, N Guljar, L Jones, TA Graham, ... bioRxiv, 594598, 2019 | 7 | 2019 |
Proteomic profiling identifies co-regulated expression of splicing factors as a characteristic feature of intravenous leiomyomatosis L Krasny, CP Wilding, E Perkins, A Arthur, N Guljar, AD Jenks, C Fisher, ... Cancers 14 (12), 2907, 2022 | 2 | 2022 |
Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma WGJ Kerrison, J Ning, L Krasny, A Arthur, N Guljar, ML Elms, A Swain, ... Cells 11 (15), 2418, 2022 | 1 | 2022 |
Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers 2022, 14, 2907 L Krasny, CP Wilding, E Perkins, A Arthur, N Guljar, AD Jenks, C Fisher, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |